STOCK TITAN

BioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, will release its second quarter 2025 financial results after market close on Thursday, August 7, 2025.

The company will host a conference call and webcast at 4:30 PM ET where management will discuss financial results and provide a business update. Investors can access the webcast through BioLife's website or join via phone using the provided toll-free numbers.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+1.44%
1 alert
+1.44% News Effect

On the day this news was published, BLFS gained 1.44%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOTHELL, Wash., July 24, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's second quarter 2025 financial results will be released after market close on Thursday, August 7, 2025. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers.  A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com/ for 90 days. 

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-second-quarter-2025-financial-results-and-business-update-on-august-7-2025-302513514.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions (BLFS) report Q2 2025 earnings?

BioLife Solutions will report Q2 2025 earnings after market close on Thursday, August 7, 2025.

How can I listen to BioLife Solutions' Q2 2025 earnings call?

You can access the webcast on BioLife's website or dial 1-833-630-0431 (US toll-free) or 1-412-317-1808 (international) at 4:30 PM ET on August 7, 2025.

What time is BioLife Solutions' Q2 2025 earnings call?

The earnings call and webcast will take place at 4:30 PM ET (1:30 PM PT) on August 7, 2025.

How long will BioLife Solutions' Q2 2025 earnings webcast be available?

The webcast replay will be available approximately two hours after the call and will be archived on the investor relations website for 90 days.
Biolife Solutions Inc

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Latest SEC Filings

BLFS Stock Data

1.19B
47.19M
2.11%
104.51%
8.23%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
BOTHELL